BeOne Medicines Ltd. (ONC)
263.46
-4.71
(-1.76%)
USD |
NASDAQ |
Jun 10, 16:00
263.46
0.00 (0.00%)
After-Hours: 16:56
BeOne Medicines SG&A Expense (Quarterly) : 556.75M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 556.75M |
| December 31, 2025 | 557.71M |
| September 30, 2025 | 529.71M |
| June 30, 2025 | 539.80M |
| March 31, 2025 | 459.29M |
| December 31, 2024 | 502.87M |
| September 30, 2024 | 455.22M |
| June 30, 2024 | 443.73M |
| March 31, 2024 | 427.43M |
| December 31, 2023 | 416.55M |
| September 30, 2023 | 364.42M |
| June 30, 2023 | 395.03M |
| March 31, 2023 | 328.50M |
| December 31, 2022 | 328.98M |
| September 30, 2022 | 322.89M |
| June 30, 2022 | 331.40M |
| March 31, 2022 | 294.57M |
| December 31, 2021 | 306.50M |
| September 30, 2021 | 269.23M |
| June 30, 2021 | 232.29M |
| March 31, 2021 | 182.11M |
| December 31, 2020 | 208.21M |
| Date | Value |
|---|---|
| September 30, 2020 | 160.84M |
| June 30, 2020 | 124.05M |
| March 31, 2020 | 107.08M |
| December 31, 2019 | 143.35M |
| September 30, 2019 | 105.00M |
| June 30, 2019 | 82.25M |
| March 31, 2019 | 57.64M |
| December 31, 2018 | 72.49M |
| September 30, 2018 | 48.82M |
| June 30, 2018 | 45.16M |
| March 31, 2018 | 28.92M |
| December 31, 2017 | 27.42M |
| September 30, 2017 | 15.64M |
| June 30, 2017 | 10.78M |
| March 31, 2017 | 8.769M |
| December 31, 2016 | 8.337M |
| September 30, 2016 | 4.722M |
| June 30, 2016 | 3.904M |
| March 31, 2016 | 3.134M |
| December 31, 2015 | 2.95M |
| September 30, 2015 | 4.361M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| CRISPR Therapeutics AG | 17.18M |
| AC Immune SA | 5.326M |
| Idorsia Ltd. | 77.58M |
| ADC Therapeutics SA | 22.60M |
| MoonLake Immunotherapeutics | 15.51M |